Splash Beverage Group (SBEV) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 May, 2026Executive summary
Revenue for Q1 2026 was $4,224, a sharp decline from $68,606 in Q1 2025, reflecting a lack of working capital and limited product sales, with only Chispo tequila generating revenue through Senor Frog locations.
The company is transitioning from beverage sales to focus on the regulated wellness and cannabinoid markets, highlighted by a proposed acquisition of Medterra CBD, LLC, though the deal remains pending.
The Copa Di Vino product line has been discontinued and its results are now classified as discontinued operations.
Financial highlights
Net loss from continuing operations for Q1 2026 was $2.14 million, compared to $3.28 million in Q1 2025.
Operating expenses decreased to $980,818 from $1,683,847 year-over-year, mainly due to reduced contract services, salaries, and marketing.
Interest expense increased to $889,455 from $637,345, primarily due to the Decathlon loan.
Net cash used in operating activities was $930,492, while net cash provided by financing activities was $1,053,541 for Q1 2026.
Cash and cash equivalents at March 31, 2026 were $381,195, up from $281,435 at year-end 2025.
Outlook and guidance
The company does not have sufficient capital to meet working capital needs for the next 12 months and is dependent on raising additional funds, including $10 million needed to close the Medterra acquisition.
Management expects the Medterra acquisition, if completed, to restore compliance with NYSE American equity requirements.
Latest events from Splash Beverage Group
- Pivoting to cannabinoid wellness, company seeks capital via equity line amid financial distress.SBEV
Registration filing - Facing liquidity issues, the company pursues a dilutive equity line and entry into the cannabinoid sector.SBEV
Registration filing - Paused operations, major losses, and a planned Medterra CBD acquisition amid severe liquidity risk.SBEV
Q4 2025 - Severe liquidity crisis and no revenue drive urgent capital raise and major dilution risk.SBEV
Registration Filing - Distressed beverage company seeks $35M ELOC, faces dilution and going concern risks.SBEV
Registration Filing - Shareholders to vote on director elections, auditor ratification, and major share issuances.SBEV
Proxy Filing - Shareholders approved increasing authorized common shares to 400 million.SBEV
AGM 2025 - Gross margins improved to 30% as revenue fell and liquidity risks persisted.SBEV
Q3 2024 - Revenue plunged and losses persisted amid liquidity and NYSE compliance risks.SBEV
Q2 2024